<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "https://jats.nlm.nih.gov/publishing/1.3/JATS-journalpublishing1-3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" article-type="research-article"><front><journal-meta><journal-id journal-id-type="issn">2607-9917</journal-id><journal-title-group><journal-title>Bulletin de la Dialyse à Domicile</journal-title></journal-title-group><issn pub-type="epub">2607-9917</issn><publisher><publisher-name>RDPLF</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.25796/bdd.v5i2.65493</article-id><article-categories><subj-group subj-group-type="heading"><subject>INTRODUCTION</subject></subj-group><subj-group subj-group-type="toc-heading"><subject>PRESENTATION OF CLINICAL CASE</subject></subj-group><subj-group subj-group-type="toc-heading"><subject>DISCUSSION</subject></subj-group><subj-group subj-group-type="toc-heading"><subject>CONCLUSION</subject></subj-group></article-categories><title-group><article-title>Peritoneal infection with Geotrichum spp in peritoneal dialysis in Dakar: a case report with literature review.</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7104-6730</contrib-id><name><surname>BA</surname><given-names>Bacary</given-names></name><xref ref-type="aff" rid="AFF-1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9838-5364</contrib-id><name><surname>Faye</surname><given-names>Maria</given-names></name><xref ref-type="aff" rid="AFF-1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5321-9741</contrib-id><name><surname>Faye</surname><given-names>Moustapha</given-names></name><xref ref-type="aff" rid="AFF-1"/></contrib><contrib contrib-type="author"><name><surname>Ka</surname><given-names>Elhadji Fary</given-names></name><xref ref-type="aff" rid="AFF-1"/></contrib><aff id="AFF-1">CHU Aristide Le Dantec</aff></contrib-group><author-notes><fn fn-type="coi-statement"><label>Conflict of Interest</label><p>The authors declare no conflict of interest for this article.</p></fn></author-notes><pub-date date-type="pub" iso-8601-date="2022-5-2" publication-format="electronic"><day>2</day><month>5</month><year>2022</year></pub-date><volume>5</volume><issue>2</issue><fpage>105</fpage><lpage>109</lpage><history><date date-type="received" iso-8601-date="2022-3-22"><day>22</day><month>3</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-4-24"><day>24</day><month>4</month><year>2022</year></date></history><permissions><copyright-statement>Copyright (c) 2022 Bacary BA</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Bacary BA</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by/4.0</ali:license_ref><license-p>This work is licensed under a Creative Commons Attribution 4.0 International License.</license-p></license></permissions><self-uri xlink:href="https://bdd.rdplf.org/index.php/bdd/article/view/65493" xlink:title="Peritoneal infection with Geotrichum spp in peritoneal dialysis in Dakar: a case report with literature review.">Peritoneal infection with Geotrichum spp in peritoneal dialysis in Dakar: a case report with literature review.</self-uri><abstract><p>Fungal peritoneal infection is a relatively rare but serious complication of peritoneal dialysis. It is associated with a high risk of technical failure and mortality, particularly in the event of late diagnosis. Most of these fungal infections are associated with the <italic>Candida</italic> genus. However, in recent years, we have observed an emergence of new fungal species with established pathogenicity in peritoneal dialysis. We report the first case of fungal peritoneal infection due to <italic>Geotrichum spp</italic> that occurred in our peritoneal dialysis unit in Dakar in Senegal.</p></abstract><kwd-group><kwd>peritoneal dialysis</kwd><kwd>peritonitis</kwd><kwd>fungal peritonitis</kwd><kwd>geotrichum</kwd><kwd>Dakar</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>File created by JATS Editor</meta-name><meta-value><ext-link ext-link-type="uri" xlink:href="https://jatseditor.com" xlink:title="JATS Editor">JATS Editor</ext-link></meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec><title>INTRODUCTION</title><p>Over the past 20 years, the incidence of fungal infections, both superficial and deep, has increased dramatically. These pathologies most often occur in immunocompromised patients (those who have undergone organ transplants, dialysis, bone marrow transplants, chemotherapy, those taking immunosuppressants, etc.). If the patients and the treatments have evolved, the fungi involved in the pathologies have also diversified. Indeed, we have observed the emergence of species previously unknown to the medical community, as well as the re-emergence of already known species.</p><p>The latter are responsible for new clinical forms, occurring in different in different circumstances <xref ref-type="bibr" rid="BIBR-1">[1]</xref>. Fungal peritoneal infection (PI) is a relatively rare but serious complication in peritoneal dialysis (PD). It is associated with a high risk of technical failure and death, especially in the case of late diagnosis <xref ref-type="bibr" rid="BIBR-2">[2]</xref>. A high mortality rate has been reported <xref ref-type="bibr" rid="BIBR-3">[3]</xref>. Although its prognosis is bleak, its prevalence is highly variable throughout the world, ranging from 2 to 23.8% in industrialized and developing countries, respectively <xref ref-type="bibr" rid="BIBR-2">[2]</xref>. In the entire RDPLF database, 1.2% of peritonitis cases over the last 10 years have been fungal, with no cases of Geotrichum [personal communication RDPLF]. Candida is the most common genus, implicated in 80% to 90% of cases of fungal PI <xref ref-type="bibr" rid="BIBR-4">[4]</xref>. Indeed, in Mexico, out of 149 cases of PI reported in 2013, 12 were of fungal origin. Of these, 6 were linked to Candida albicans. <xref ref-type="bibr" rid="BIBR-5">[5]</xref>.</p><p>In India, the Candida genus accounted for 50% of fungal PI in CAPD <xref ref-type="bibr" rid="BIBR-6">[6]</xref>. Other fungi such as Fusarium, Aspergillus, Penicillium <xref ref-type="bibr" rid="BIBR-7">[7]</xref>, Cryptococcus <xref ref-type="bibr" rid="BIBR-8">[8]</xref>, have been described as agents responsible for PI in CAPD. PI due to Geotrichum has also been reported. We found one case in 1987 <xref ref-type="bibr" rid="BIBR-9">[9]</xref>and another in Mexico in 2018 <xref ref-type="bibr" rid="BIBR-4">[4]</xref>.</p><p>In Senegal, the incidence of PI is 1.92 person-years <xref ref-type="bibr" rid="BIBR-10">[10]</xref>and the only fungal species found so far has been Candida albicans. We report here the case of a patient from our unit in Dakar who presented with a PI due to Geotrichum spp.</p></sec><sec><title>PRESENTATION OF CLINICAL CASE</title><p>This was a 54-year-old patient who had been in CAPD for 9 months, and whose initial nephropathy was benign nephroangiosclerosis, which had been discovered 2 years prior. In her antecedents, we noted hypertensive heart disease under perindopril 10mg/d. On July 25, 2019, she presented with acute, intense abdominal pain without vomiting or diarrhea. On examination, her blood pressure was 160/80 mmHg and her temperature was 36.7°C. Her catheter exit site was clean and the drainage fluid cloudy. Her abdomen was distended, tender with defense on palpation.</p><p>The diagnosis of PI was confirmed by cytology of the peritoneal fluid, which was 2620 leukocytes/mm3 with neutrophil predominance (85%). A probabilistic antibiotic therapy based on ceftriaxone 1g/24h intraperitoneally associated with oral ciprofloxacin 500mg/24h was started. The initial evolution was marked by a decrease in the number of leukocytes in the liquid after 72 hours of treatment (L= 2000 /mm3). However, the drainage fluid was still cloudy, and the patient’s abdominal pain persisted. Bacteriological culture was negative. After 7 days of treatment, a new cytology performed counted 2500 leukocytes/mm3, still predominantly neutrophilic (70%). A new culture of the drainage liquid intended to locate opportunistic germs, a parasitological and mycological examination were requested. Mycological examination had isolated Geotrichum spp. A treatment based on oral fluconazole (200mg in the loading dose, then 100mg/d) was administered and the PD catheter was removed after 5 days. The patient was transferred to hemodialysis. After 2 hemodialysis sessions, she died in cardiogenic shock.</p></sec><sec><title>DISCUSSION</title><p>Geotrichum spp. are fungi belonging to the phylum Ascomycota, class Hemiascomycetes, order Saccharomycetales, family Dipodascaceae <xref ref-type="bibr" rid="BIBR-11">[11]</xref>;<xref ref-type="bibr" rid="BIBR-12">[12]</xref>. Currently, three species of Geotrichum have been described as human pathogens: G. candidum, G. capitatum and G. clavatum <xref ref-type="bibr" rid="BIBR-11">[11]</xref>;<xref ref-type="bibr" rid="BIBR-13">[13]</xref>. They are macroscopically identical to each other, and only the analysis of their microscopic and physiological characters makes it possible to differentiate the species. They are cosmopolitan filamentous yeasts usually present in soil, manure, fruits and dairy products, especially cheeses <xref ref-type="bibr" rid="BIBR-16">[16]</xref>. In humans, Geotrichum can be most often isolated in the digestive tract, and sometimes in the respiratory tract and skin <xref ref-type="bibr" rid="BIBR-13">[13]</xref>;<xref ref-type="bibr" rid="BIBR-14">[14]</xref>. These are commensal species that can become pathogenic in certain circumstances, particularly in PD. Two cases of Geotrichum PI similar to our case have been described (1987; 2018) <xref ref-type="bibr" rid="BIBR-9">[9]</xref>;<xref ref-type="bibr" rid="BIBR-4">[4]</xref>. If in our case it was a primary infection with Geotrichum spp, in the Mexican one <xref ref-type="bibr" rid="BIBR-4">[4]</xref>it was instead a recurrence of Geotrichum candidum after 2 months with a history of bacterial PI. All these cases had been in CAPD for a few months and had hypertension as a comorbidity.</p><p>The risk factors that generally predispose patients to the development of fungal PI are long-term antibiotic therapy, recent episodes of bacterial peritoneal infection, extra-peritoneal Candida infection, immunosuppression, hospitalization, prolonged stays in PD with the same peritoneal catheter and advanced age <xref ref-type="bibr" rid="BIBR-15">[15]</xref>;<xref ref-type="bibr" rid="BIBR-3">[3]</xref>;. None of these risk factors was found in our case, which suggests that the infection was caused by other, unknown factors or was linked to manipulations at home during bag changes.</p><p>The clinical manifestations of fungal PI are similar to bacterial ones, and the diagnosis should be considered in the event of a negative culture and the persistence of cloudy dialysis fluid and symptoms despite antibiotic treatment <xref ref-type="bibr" rid="BIBR-4">[4]</xref>. In our clinical case, a fungal PI was suspected in view of the persistence of the symptoms after 7 days of antibiotic therapy.</p><p>The identification of the liquid drainage by mycological examination is the most important data to confirm the diagnosis and start an appropriate treatment. In the literature, the results of this antifungal treatment are variable. Amphotericin B, fluorocytosis, ketoconazole, miconazole, econazole, fluconazole, and more recently posaconazole and voriconazole are the most commonly used antifungals. Fluconazole has some advantages over other antifungals. Its bioavailability in the peritoneal cavity when administered orally or intravenously and good tolerance of it are the main ones <xref ref-type="bibr" rid="BIBR-4">[4]</xref>. According to the latest update of the ISPD recommendations <xref ref-type="bibr" rid="BIBR-17">[17]</xref>, in addition to antifungal treatment, which must be carried out for at least 14 days and sometimes beyond 4 weeks, early catheter removal remains the cornerstone of the treatment of fungal PI. In the case of our patient, the catheter was removed after 5 days of antifungal treatment.</p><p>It should be noted that the ideal antifungal treatment has not yet been identified. The appropriate dosage, the routes of administration or the duration of the treatment have not been established, though it is agreed that treatment should last at least two weeks. Prophylaxis with fluconazole (100 mg/day), ketoconazole (200 mg/day) or nystatin has been shown to be effective in reducing the incidence of fungal PI <xref ref-type="bibr" rid="BIBR-4">[4]</xref>.</p><p>In this case, the patient died of cardiogenic shock following decompensation of her heart disease. This often unfavorable evolution has been reported several times in the literature <xref ref-type="bibr" rid="BIBR-2">[2]</xref>. Nevertheless, the mortality rate in the world remains variable, ranging from 5 to 40% <xref ref-type="bibr" rid="BIBR-2">[2]</xref>. It is higher in patients with oligoanuria <xref ref-type="bibr" rid="BIBR-18">[18]</xref>and in those whose peritoneal catheters were not removed quickly once infections were diagnosed <xref ref-type="bibr" rid="BIBR-1">[1]</xref>;<xref ref-type="bibr" rid="BIBR-2">[2]</xref>. In a study by Wang et al.<xref ref-type="bibr" rid="BIBR-19">[19]</xref>, catheters were removed in 83% of cases of fungal PI after an average delay of 7 days, and the mortality rate was 44.3%. In another study, PD catheters were removed in all patients at diagnosis, and the mortality rate was only 20% <xref ref-type="bibr" rid="BIBR-18">[18]</xref>. The delay in diagnosis and management could explain the unfavorable evolution in our patient.</p></sec><sec><title>CONCLUSION</title><p>Fungal peritonitis due to Geotrichum remains very rare in the literature, and this case was a first in our center. This experience should prompt clinicians to always consider it in the face of persistent signs of PI despite appropriate antibiotic therapy.</p></sec></body><back><ref-list><title>References</title><ref id="BIBR-1"><element-citation publication-type="article-journal"><article-title>Émergence de nouveaux champignons pathogènes en médecine: revue générale</article-title><source>RFL</source><volume>416</volume><person-group person-group-type="author"><name><surname>Chabasse</surname><given-names>D.</given-names></name><name><surname>Pihet</surname><given-names>M.</given-names></name><name><surname>Bouchara</surname><given-names>J.P.</given-names></name></person-group><year>2009</year><fpage>71</fpage><lpage>86</lpage><page-range>71-86</page-range></element-citation></ref><ref id="BIBR-2"><element-citation publication-type="article-journal"><article-title>Fungal peritonitis in peritoneal dialysis: a 34-year single centre evaluation</article-title><source>Clin Kidney J</source><volume>11</volume><issue>6</issue><person-group person-group-type="author"><name><surname>Auricchio</surname><given-names>S.</given-names></name><name><surname>Giovenzana</surname><given-names>M.E.</given-names></name><name><surname>M</surname><given-names>Pozzi</given-names></name></person-group><year>2018</year><fpage>874</fpage><lpage>880</lpage><page-range>874-880</page-range></element-citation></ref><ref id="BIBR-3"><element-citation publication-type="article-journal"><article-title>Peritonitis fúngica en diálisis peritoneal continua ambulatoria: Descripción de 10 casos</article-title><source>Nefrol</source><volume>29</volume><person-group person-group-type="author"><name><surname>García</surname><given-names>M.P.</given-names></name><name><surname>Sola</surname><given-names>S.F.</given-names></name><name><surname>PG</surname><given-names>Marín</given-names></name></person-group><year>2009</year><fpage>534</fpage><lpage>539</lpage><page-range>534-539</page-range></element-citation></ref><ref id="BIBR-4"><element-citation publication-type="article-journal"><article-title>Peritonitis due to Geotrichum candidum in Continuous Ambulatory Peritoneal Dialysis</article-title><source>CRCM</source><volume>7</volume><person-group person-group-type="author"><name><surname>Garza</surname><given-names>J.R.C.</given-names></name><name><surname>Miranda</surname><given-names>R.S.C.</given-names></name><name><surname>AMC</surname><given-names>Garza</given-names></name></person-group><year>2018</year><fpage>232</fpage><lpage>240</lpage><page-range>232-240</page-range></element-citation></ref><ref id="BIBR-5"><element-citation publication-type="article-journal"><article-title>Etiología de peritonitis asociada a diálisis peritoneal continua ambulatoria en urgencias</article-title><source>Arch Med Urgen Méx</source><volume>5</volume><person-group person-group-type="author"><name><surname>Russi</surname><given-names>H.M.</given-names></name><name><surname>VJL</surname><given-names>Mejía</given-names></name><name><surname>Ortíz</surname><given-names>L.I.</given-names></name></person-group><year>2013</year><fpage>5</fpage><lpage>10</lpage><page-range>5-10</page-range></element-citation></ref><ref id="BIBR-6"><element-citation publication-type="article-journal"><article-title>The Risk Factors and Outcome of Fungal Peritonitis in Continuous Ambulatory Peritoneal Dialysis Patients</article-title><source>Indian JMed Microbiol</source><volume>27</volume><person-group person-group-type="author"><name><surname>Indhumati</surname><given-names>E.</given-names></name><name><surname>Chandrasekaran</surname><given-names>V.</given-names></name><name><surname>Jagadeswaran</surname><given-names>D.</given-names></name></person-group><year>2009</year><fpage>59</fpage><lpage>61</lpage><page-range>59-61</page-range></element-citation></ref><ref id="BIBR-7"><element-citation publication-type="article-journal"><article-title>Fungal Peritonitis in 15 Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD</article-title><source>Mycoses</source><volume>46</volume><person-group person-group-type="author"><name><surname>Manzano</surname><given-names>G.P.</given-names></name><name><surname>Hernández</surname><given-names>H.F.</given-names></name><name><surname>Méndez</surname><given-names>T.L.J.</given-names></name></person-group><year>2003</year><fpage>425</fpage><lpage>429</lpage><page-range>425-429</page-range></element-citation></ref><ref id="BIBR-8"><element-citation publication-type="article-journal"><article-title>Cryptococcal Peritonitis: Report of a CaseDeveloping during Continuous Ambulatory Peritoneal Dialysis and Review of the Literature</article-title><source>Clin Infect Dis</source><volume>17</volume><person-group person-group-type="author"><name><surname>Yinnon</surname><given-names>A.M.</given-names></name><name><surname>A</surname><given-names>Solages</given-names></name><name><surname>Treanor</surname><given-names>J.J.</given-names></name></person-group><year>1993</year><fpage>736</fpage><lpage>741</lpage><page-range>736-741</page-range></element-citation></ref><ref id="BIBR-9"><element-citation publication-type=""><article-title>as an agent of peritonitis in continuous ambulatory peritoneal dialysis (CAPD).Clin Nephrol</article-title><volume>28</volume><issue>4</issue><person-group person-group-type="author"><name><surname>Hernández</surname><given-names>J.J.</given-names></name><name><surname>Martínez</surname><given-names>M.L.</given-names></name><name><surname>Gallego</surname><given-names>J.L.</given-names></name><name><surname>Fernández</surname><given-names>F.J.</given-names></name><name><surname>sp</surname><given-names>Botella J.Geotrichum</given-names></name></person-group><year>1987</year></element-citation></ref><ref id="BIBR-10"><element-citation publication-type="chapter"><article-title>Infections péritonéale en dialyse péritonéale au service de néphrologie de l’hopital Aristide Le Dantec</article-title><source>Imane Jouai. Mémoire de Médecine 2019. Dakar:UCAD ;2017</source><page-range>265</page-range></element-citation></ref><ref id="BIBR-11"><element-citation publication-type="article-journal"><article-title>A revision of the genus Geotrichum and its teleomorphs</article-title><source>Stud Mycol</source><volume>29</volume><issue>1</issue><person-group person-group-type="author"><name><surname>Hoog GS</surname></name><name><surname>MT</surname><given-names>Smith</given-names></name><name><surname>E</surname><given-names>Gueho</given-names></name></person-group><year>1986</year><page-range>131</page-range></element-citation></ref><ref id="BIBR-12"><element-citation publication-type="article-journal"><article-title>Re-examination of some species of the genus Geotrichum link: Fr</article-title><source>Antonie Van Leeuwenhoek</source><volume>77</volume><person-group person-group-type="author"><name><surname>Smith</surname><given-names>M.T.</given-names></name><name><surname>Poot</surname><given-names>G.A.</given-names></name><name><surname>Cock</surname><given-names>A.W.</given-names></name></person-group><year>2000</year><fpage>71</fpage><lpage>81</lpage><page-range>71-81</page-range></element-citation></ref><ref id="BIBR-13"><element-citation publication-type="article-journal"><article-title>DNA relatedness, taxonomy and medicalsignificance of Geotrichum capitatum</article-title><source>J Clin Microbiol</source><volume>25</volume><person-group person-group-type="author"><name><surname>Gueho</surname><given-names>E.</given-names></name><name><surname>Hoog</surname><given-names>G.S.</given-names></name><name><surname>Smith</surname><given-names>M.T.</given-names></name><name><surname>Meyer</surname><given-names>S.A.</given-names></name></person-group><year>1987</year><fpage>1191</fpage><lpage>4</lpage><page-range>1191-4</page-range></element-citation></ref><ref id="BIBR-14"><element-citation publication-type="article-journal"><article-title>Geotrichum candidum an opportunistic agent of mycotic diseases</article-title><source>Mycoses</source><volume>31</volume><issue>363</issue><person-group person-group-type="author"><name><surname>Buchta</surname><given-names>V.</given-names></name><name><surname>Otcenasek</surname><given-names>M.</given-names></name></person-group><year>1988</year><page-range>70</page-range></element-citation></ref><ref id="BIBR-15"><element-citation publication-type="article-journal"><article-title>Aspectos clínicos y microbiológicos de la peritonitis fúngica en diálisis peritoneal</article-title><source>Nefrol</source><person-group person-group-type="author"><name><surname>AR.</surname><given-names>García</given-names></name><name><surname>MP</surname><given-names>García</given-names></name></person-group><year>2009</year><fpage>29506</fpage><lpage>517</lpage><page-range>29506-517</page-range></element-citation></ref><ref id="BIBR-16"><element-citation publication-type="article-journal"><article-title>Peritonitis en diálisis peritoneal</article-title><source>Nefrol</source><volume>26</volume><person-group person-group-type="author"><name><surname>Montenegro</surname><given-names>J.</given-names></name><name><surname>Molina</surname><given-names>A.</given-names></name><name><surname>Rodríguez</surname><given-names>P.J.R.</given-names></name></person-group><year>2006</year><fpage>115</fpage><lpage>131</lpage><page-range>115-131</page-range></element-citation></ref><ref id="BIBR-17"><element-citation publication-type="article-journal"><article-title>ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment</article-title><source>PDI</source><volume>42</volume><issue>2</issue><person-group person-group-type="author"><name><surname>KT.P</surname><given-names>Li</given-names></name><name><surname>KM</surname><given-names>Chow</given-names></name><name><surname>Y</surname><given-names>Cho</given-names></name></person-group><year>2022</year><fpage>110</fpage><lpage>153</lpage><page-range>110-153</page-range><pub-id pub-id-type="doi">10.1177/08968608221080586</pub-id></element-citation></ref><ref id="BIBR-18"><element-citation publication-type="article-journal"><article-title>Fungal peritonitis in peritoneal dialysis: an analysis of 21 cases</article-title><source>Int Urol Nephrol</source><volume>43</volume><person-group person-group-type="author"><name><surname>Aydin</surname><given-names>U.</given-names></name><name><surname>Ismail</surname><given-names>K.</given-names></name><name><surname>Murat</surname><given-names>H.S.</given-names></name><name><surname>Bulent</surname><given-names>T.</given-names></name><name><surname>Oktay</surname><given-names>O.</given-names></name><name><surname>Cengiz</surname><given-names>U.</given-names></name></person-group><year>2011</year><fpage>211</fpage><lpage>213</lpage><page-range>211-213</page-range></element-citation></ref><ref id="BIBR-19"><element-citation publication-type="article-journal"><article-title>Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center</article-title><source>Am J Kidney Dis.2000;36:1183–1192</source><person-group person-group-type="author"><name><surname>Wang</surname><given-names>A.Y.</given-names></name><name><surname>Yu</surname><given-names>A.W.</given-names></name><name><surname>PK</surname><given-names>Li</given-names></name></person-group></element-citation></ref></ref-list></back></article>
